Hey Doog, not much to say, just enjoying the run-up, like most, which, as we all know, started with the halted stock from the large percentage gain based on "rumor" with no collaborative pr.
I believe the company has methodically issued these pr's and now big money is getting on board thus the hold pattern to load up and rest the chart a bit. Our golden cross is in play. More volume than we have ever seen before in such a short period of time.
I see no-one commented on Samsa's post last week citing the public summary changes from the FDA, published 10-6, putting more meat into patent claims, made by companies, being supported by the data in the NDA's filing's. I think IPCI knew those were coming but until they had the actual revisions in hand choose to give a last generic public comment of the filing to be filed by the end of 4th qtr (Nov) to give time for the review. The changes aren't effective until 12-6-16 but why chance a potential problem filing, without feeling compliance is at hand. Anyhow that's how I see it. Hopefully we'll hear an update on that filing at the conference next week.